Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023March 1, 2023 Elixinol Wellness reported a 2022 year-end loss of A$10.5m, a 38% improvement on the previous year, […]
Two-year study of 4,000 patients reveals cannabis is ‘safe and efficacious’ by Steve Jones November 23, 2022November 25, 2022
We need to talk about flower – the vexing challenge of dried cannabis by Steve Jones September 21, 2022October 6, 2022
We’re coming for you, TGA warns rule-breaking clinics after issuing 32 cease and desist orders by Steve Jones July 15, 2021July 22, 2021
New evidence shows opioid use and pain decline, quality of life goes up after cannabis treatment by Martin Lane June 10, 2021June 16, 2021
Emyria and Cann Group ink deal to fast track over-the-counter CBD registration by Martin Lane March 29, 2021August 13, 2021
